Home/Applied Therapeutics/Charles Silberstein

CS

Charles Silberstein

Chief Financial Officer

Applied Therapeutics

Therapeutic Areas

Rare Metabolic Diseases Neurology

Applied Therapeutics Pipeline

Drug	Indication	Phase
Govorestat (AT-007)	Classic Galactosemia	Phase 3
AT-001	Diabetic Cardiomyopathy	Phase 3

Leadership Team at Applied Therapeutics

Shoshana Shendelman

Founder, CEO, and Chair of the Board

Riccardo Perfetti

Chief Medical Officer

Alexandria Forbes

President and Head of R&D

View full Applied Therapeutics profile